Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Edgar, D. Griffiths, E. Sapey, R. Stockley (Birmingham, United Kingdom). Investigating change in the COPD assessment test (CAT) within α-1 antitrypsin deficiency (A1ATD). Eur Respir J 2011; 38: Suppl. 55, 3514

Member's Comments

No comment yet.

Related content which might interest you: Association between alpha1 antitrypsin (AAT) circulating polymers (CP) and lung and liver disease in patients with AAT deficiency (AATD). Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases Year: 2021 CT scan derived emphysema scores correlate with spirometry and gas exchange but not acute exacerbation rates (AER) or COPD assessment test (CAT) in COPD subjects with and without alpha-1-antitrypsin (AAT) deficiency Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 COPD assessment test (CAT) in the evaluation of COPD Source: Annual Congress 2012 - COPD: epidemiology and varia Year: 2012 Aα360: A measure of disease and treatment efficacy in alpha-1-antitrypsin (A1AT) deficiency Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 Is the COPD assessment test (CAT) useful in our patients? Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care Year: 2012 The results of alpha-1 antitrypsine (AAT) phenotyping in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 260s Year: 2002 Patterns of exacerbations in alpha 1 antitrypsin deficiency (AATD) Source: International Congress 2015 – Connective tissue disorders Year: 2015 Relationship between COPD assessment test (CAT) and declines of lung function in COPD patients Source: Annual Congress 2012 - COPD: epidemiology and varia Year: 2012 Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Intra-epithelial polymerization, accumulation and secretion of alpha1 antitrypsin (AAT) Z polymers in the lung of patients with alpha-1 antitrypsin deficiency (AATD) Source: Annual Congress 2010 - Epithelial cell biology Year: 2010 Effects of double dose alpha 1 antitrypsin (AAT) therapy on cytokine pathways in AAT Deficiency (AATD) Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Functional alterations of small airways in patients with alpha-1 antitrypsin deficiency (AATD) in a longitudinal study Source: Eur Respir J 2005; 26: Suppl. 49, 361s Year: 2005 Predicting clinical course of alpha 1 anti-trypsin deficiency (AATD) using GOLD 2011 classification Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Prevalence of alpha-1-antitrypsin deficiency (A1AD) in patients with COPD. Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 CAT (COPD assessment test) as outcome parameter of pulmonary rehabilitation (PR) in COPD Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life Year: 2011 Alpha 1 antitrypsin (A1AT) deficiency in children with asthma in Brazil Source: Eur Respir J 2003; 22: Suppl. 45, 499s Year: 2003 The use of impulse oscillometry (IOS) in the differentiation of bronchiectasis and emphysema in patients with alpha1 antitrypsin deficiency (α1-ATD) Source: Annual Congress 2004 - Airway resistance: application and technique Year: 2004 Long-term changes in the COPD assessment test (CAT) after pulmonary rehabilitation Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life Year: 2011 Frequency of α-1 antitrypsin deficiency (AATD) in a population screening in an high risk area (Val Trompia, Italy) Source: Eur Respir J 2006; 28: Suppl. 50, 453s Year: 2006